Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Unicycive Therapeutics (UNCY) Interest Coverage Ratio (2020 - 2025)

Unicycive Therapeutics filings provide 3 years of Interest Coverage Ratio readings, the most recent being 463.05 for Q4 2024.

  • On a quarterly basis, Interest Coverage Ratio fell 39.36% to 463.05 in Q4 2024 year-over-year; TTM through Dec 2024 was 452.35, a 76.37% decrease, with the full-year FY2025 number at 415.73, up 8.1% from a year prior.
  • Interest Coverage Ratio hit 463.05 in Q4 2024 for Unicycive Therapeutics, down from 416.73 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 135.06 in Q2 2023 to a low of 1851.33 in Q3 2022.
  • Median Interest Coverage Ratio over the past 3 years was 438.47 (2024), compared with a mean of 657.63.
  • Biggest five-year swings in Interest Coverage Ratio: skyrocketed 82.18% in 2023 and later crashed 242.48% in 2024.
  • Unicycive Therapeutics' Interest Coverage Ratio stood at 1775.0 in 2022, then soared by 81.28% to 332.26 in 2023, then plummeted by 39.36% to 463.05 in 2024.
  • The last three reported values for Interest Coverage Ratio were 463.05 (Q4 2024), 416.73 (Q3 2024), and 462.56 (Q2 2024) per Business Quant data.